1-4 of 4
Brian Gordon
Close
Sort by
Journal Articles

Talen Mediated Therapeutic Gene Editing Strategy for ß-Hemoglobinopathies

Christopher Lux, MDPhD, Kyle Jacoby, PhD, Sowmya Pattabhi, PhD, Julia Yang, BS, Olivier Humbert, PhD, Brian Gordon, MS, Irwin D. Bernstein, MD, David J. Rawlings, MD, Andrew M. Scharenberg, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3340.
https://doi.org/10.1182/blood.V130.Suppl_1.3340.3340
Published: 2017
Journal Articles

Bispecific SCORPION™ Molecules Effectively Redirect T-Cell Cytotoxicity Toward CD19-Expressing Tumor Cells

Ruth A. Chenault, Rebecca Gottschalk, Gabriela Hernandez-Hoyos, PhD, Jennifer Wiens, Brian Gordon, Jennifer Klee, Jessica Bienvenue, Maria Dasovich, John Kumer, Megan Aguilar, Jeannette Bannink, Catherine J. McMahan, PhD, Sateesh Natarajan, PhD, Paul A. Algate, PhD, John W. Blankenship, PhD
Journal: Blood
Blood (2012) 120 (21): 3722.
https://doi.org/10.1182/blood.V120.21.3722.3722
Published: 2012
Journal Articles

TRU-016, An Anti-CD37 SMIP™ Biologic, In Combination with Other Therapeutic Drugs In Models of Non-Hodgkin's Lymphoma

Paul A. Algate, PhD, Jennifer Wiens, Christy Nilsson, Mien Sho, Debra T. Chao, PhD, Gary C. Starling, PhD, John C. Byrd, MD, Brian Gordon
Journal: Blood
Blood (2010) 116 (21): 3931.
https://doi.org/10.1182/blood.V116.21.3931.3931
Published: 2010
Journal Articles

CD37 Is a Potential Therapeutic Target for B-Cell Non-Hodgkin Lymphoma

Xiaoxian Zhao, PhD., Suzanne Ybarra, Lisa Durkin, Mien Sho, Neeraj Kumar, Brian Gordon, Paul Algate, Gary Starling, PhD, Debra Chao, Ph.D., Eric Hsi, MD
Journal: Blood
Blood (2010) 116 (21): 3098.
https://doi.org/10.1182/blood.V116.21.3098.3098
Published: 2010